GlaxoSmithKline Pakistan Limited announced that the board of directors of the company in their meeting held on March 11, 2020 recommended final cash dividend for the year ended Dec. 31, 2019 at PKR 6 per share that is 60%. The entitlement will be paid to the shareholders whose names will appear in the register of members on April 21, 2020.